GGrantIndex
Sort

10,829 grants matching car t

The Family Input for Quality and Safety (FIQS) Study

$664,490
Naomi Shula Bardach · University Of California, San Francisco · R01 · FY2022 · HD

Innovative Physical Activity Interventions for Overweight Latinos

$664,486
Abby C King · Stanford University · R01 · FY2017 · DK

Probiotic guided CAR-T therapy (ProCARs) for breast cancer

$664,480
Tal Danino · Columbia Univ New York Morningside · R01 · FY2023 · EB

Creating an artificial intelligence therapy-to-data feedback loop for child developmental healthcare

$664,314
Dennis Paul Wall · Stanford University · R01 · FY2020 · LM

Health Promotion Coaching/Vaccine for Homeless Parolees

$664,263
Adeline M Nyamathi · University Of California Los Angeles · R01 · FY2010 · DA

Evaluation of mHealth strategies to optimize adherence and efficacy of PMTCT/ART

$664,262
Grace C John-Stewart · University Of Washington · R01 · FY2016 · HD

BAFF-R CAR T cell therapy for ALL

$664,070
Larry W Kwak · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA

Image-guided cancer therapy using heat activatable CAR T cells

$664,037
Stanislav Y Emelianov · Georgia Institute Of Technology · R01 · FY2023 · EB

Home ECG Monitoring to Detect Allograft Rejection Following Heart Transplantation

$664,032
Barbara J Drew · University Of California, San Francisco · R01 · FY2012 · NR

Flow cytometric evaluation of biomarkers

$663,591
Hao-Wei Wang · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

Third-party “off the shelf” mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT

$663,330
Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2021 · HL

Third-party “off the shelf” mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT

$663,330
Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2022 · HL

Third-party “off the shelf” mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT

$663,330
Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2020 · HL

Optical Superresolution Microscopy (Nanoscopy)

$663,259
Jay R Knutson · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

RACE-CARS DCC 2/2

$663,145
Hussein Al-Khalidi · Duke University · U24 · FY2024 · HL

Designer extracellular vesicles for cancer therapy

$662,946
Xiaowei Xu · University Of Pennsylvania · R01 · FY2024 · CA

T cell migration and cardiovascular toxicity in immunotherapy

$662,810
Minsoo Kim · University Of Rochester · R01 · FY2025 · AI

Attacking the Immunopeptidome of Ewing Sarcoma

$662,764
Crystal Mackall · Stanford University · U01 · FY2024 · CA

Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study

$662,560
Joshua Aiden Hill · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA

Efficacy and immune effects of anakinra prophylaxis for neurologic toxicity and cytokine release syndrome in patients with lymphoma receiving axicabtagene ciloleucel

$662,340
Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2024 · CA

Label-free imaging of CAR T cell metabolism

$662,022
Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2023 · CA

A Hybrid Mobile Phone Family Intervention to Prevent Childhood Obesity

$661,972
Alma D Guerrero · University Of California Los Angeles · R01 · FY2022 · MD

CAR T Cells for Advanced Thyroid Cancer

$661,926
Moonsoo M. Jin · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA

Animal and Clinical Core

$661,849
Jeffrey R Fineman · Florida International University · P01 · FY2023 · HL

Animal and Clinical Core

$661,849
Jeffrey R Fineman · Florida International University · P01 · FY2022 · HL